American Journal of Human Genetics Review Time
American Journal of Human Genetics's review timeline, where delays usually happen, and what the timing means if you are preparing to submit.
Senior Researcher, Molecular & Cell Biology
Author context
Specializes in molecular and cell biology manuscript preparation, with experience targeting Molecular Cell, Nature Cell Biology, EMBO Journal, and eLife.
What to do next
Already submitted to American Journal of Human Genetics? Use this page to interpret the status and choose the next step.
The useful next step is understanding what the status usually means at American Journal of Human Genetics, how long the wait normally runs, and when a follow-up is actually reasonable.
American Journal of Human Genetics review timeline: what the data shows
Time to first decision is the most actionable number. What happens after varies by manuscript and reviewer availability.
What shapes the timeline
- Desk decisions are fast. Scope problems surface within days.
- Reviewer availability is the main variable after triage. Specialized topics take longer to assign.
- Revision rounds reset the clock. Major revision typically adds 6-12 weeks per round.
What to do while waiting
- Track status in the submission portal — status changes signal active review.
- Wait at least the journal's stated median before sending a status inquiry.
- Prepare revision materials in parallel if you expect a revise-and-resubmit decision.
Quick answer: American Journal of Human Genetics review time is one of the clearer flagship-journal cases because the journal actually publishes a first-decision target. AJHG says the editors make every effort to reach decisions within 4 weeks of the submission date. The same official description says all submissions are evaluated in depth by the editors first, and papers that pass that screen go to at least two reviewers who have agreed in advance to review rapidly. In practice, that means AJHG is usually a weeks-not-days journal. The first real question is not only speed. It is whether the paper reads like broad human genetics quickly enough to justify full review.
AJHG timing signals at a glance
Metric | Current value | What it means for authors |
|---|---|---|
Official first-decision target | Within 4 weeks | The journal gives a real front-end timing expectation |
Official reviewer model | At least 2 reviewers | Reviewed papers go through a normal but serious expert screen |
Official editorial triage | All submissions evaluated in depth by editors first | Misfit papers can stop before a long external-review path |
Official revision window | Generally 4 weeks | Revisions are expected to be focused and disciplined |
Official revision policy | Only 1 revised version considered | The journal does not want endless iterative rounds |
Publication model | Rolling online publication before monthly issues | Post-acceptance release is not the main bottleneck |
Impact Factor (JCR 2024) | 8.1 | Strong enough that editorial selectivity stays high |
5-year JIF | 9.6 | AJHG papers continue to matter after the first 2-year window |
Resurchify SJR | 4.531 | Strong Scopus prestige signal for a field-owned flagship |
Resurchify h-index | 339 | Deep archive and long-lived field influence |
The most useful line in that table is the first one. AJHG does not force authors to guess the first-decision target.
What the official sources do and do not tell you
The official ASHG materials tell you several things clearly.
They tell you:
- AJHG is ASHG's flagship journal
- all submissions are evaluated in depth by the editors
- papers that clear that bar go to at least two rapid reviewers
- the editors try to reach decisions within 4 weeks
- revisions, when requested, are usually allowed 4 weeks
- only one revised version is generally considered
They do not tell you:
- a public split between desk decisions and reviewed decisions
- a public median for accepted-paper total handling time
- a public dashboard of average reviewer turnaround by stage
So the right way to read AJHG is straightforward. The front-end clock is officially published. The rest of the process is best understood from the journal's editorial posture.
A practical timeline authors can actually plan around
Stage | Practical expectation | What is happening |
|---|---|---|
Initial editorial assessment | Early part of the first 4 weeks | Editors decide whether the manuscript has broad enough human-genetics consequence |
Reviewer selection and first round | Still inside the journal's stated first-decision effort window when possible | Papers that look plausible go to at least 2 rapid reviewers |
First decision | Targeted within 4 weeks | Could be reject, revise, or another editorial outcome |
Revision | About 4 weeks if invited | The journal expects a disciplined, non-open-ended response |
Post-revision decision | Often faster than the first pass because only 1 revised version is generally considered | The revision is supposed to settle the core concerns |
Post-acceptance release | Rolling online | Publication lag is usually not the main author problem |
This is not a journal that advertises endless cycles. The public signals point to a cleaner first decision and a tighter revision structure.
Why AJHG can feel fast for some papers and slow for others
AJHG often feels fast when the editorial call is easy.
That usually means one of two things:
- the paper is obviously too narrow or too indirect for flagship human genetics
- the paper is obviously well-owned by the journal and easy to send out
It feels slower when the manuscript is scientifically strong but editorially harder to place. Common reasons are:
- association results with a weaker interpretation layer than the title implies
- methods papers whose real audience is narrower than the broader genetics field
- model-organism work where human relevance is present but not yet load-bearing
- disease papers that are strong but more clinically narrow than AJHG's broad field readership expects
So the delay variable is often field ownership, not pure reviewer speed.
Desk timing and what to do while waiting
If you are waiting on AJHG, the best use of the time is to stress-test the field-level claim.
- make the human-genetics consequence more explicit in the abstract
- tighten the explanation of why the finding matters beyond one local disease niche
- prepare a cleaner answer for how the result changes current genetics practice or understanding
- check whether the paper still feels flagship-level if the cover letter is removed
AJHG is a journal where first-read framing changes timing because it changes whether the editors see a full-review case at all.
Timing context from the journal's citation position
Metric | Value | Why it matters for review time |
|---|---|---|
Impact Factor | 8.1 | A respected flagship can screen firmly at the front end |
5-year JIF | 9.6 | Long-tail field value reinforces selectivity |
Category rank | 12/191 | AJHG is strong enough that it does not need to stretch for volume |
Percentile | 94th | Broad human-genetics fit matters more than just technical correctness |
That profile supports a simple reading: AJHG can afford to say no quickly to papers that do not look like community-wide human genetics work.
Longer-run journal trend and what it means for timing
Year | Impact Factor |
|---|---|
2017 | ~8.8 |
2018 | ~9.9 |
2019 | ~9.9 |
2020 | 9.9 |
2021 | 11.1 |
2022 | 9.8 |
2023 | 8.1 |
2024 | 8.1 |
The journal has normalized after the 2021 citation spike and is now steady at 8.1. That stability matters because it suggests AJHG is operating as a durable flagship field journal, not reacting to short-run citation volatility. In timing terms, that usually means the editorial bar stays coherent.
Directionally, AJHG is down from 9.8 in 2022 to 8.1 in 2023 and flat at 8.1 in 2024 on the JCR side, while the Scopus impact score is up from 6.82 in 2023 to 7.17 in 2024.
How AJHG compares with nearby journals on timing
Journal | Timing signal | Editorial posture |
|---|---|---|
AJHG | Official effort to decide within 4 weeks | Broad human-genetics flagship with a community gate |
Nature Genetics | Often harder editorial threshold with broader biology demands | Higher glamour, broader consequence |
Genome Research | Can be a cleaner home for genomics-heavy papers | More genomics-centered ownership |
Genetics in Medicine | Better for clinically implemented genetics | More clinical-facing than field-flagship genetics |
This is why frustration about AJHG timing is often really frustration about journal ownership. The paper may be publishable, but not necessarily publishable here.
Readiness check
While you wait on American Journal of Human Genetics, scan your next manuscript.
The scan takes 60 seconds. Use the result to decide whether to revise before the decision comes back.
What review-time data hides
Review-time discussion hides a few things that matter more than the clock:
- the official 4-week target is a first-decision target, not a guarantee of acceptance or a total-cycle promise
- the one-revision norm means invited revisions carry real pressure
- early editorial rejection often means the paper was mispositioned, not that the process failed
- reviewer speed matters less than whether the editors think the work belongs on the AJHG stage
In our pre-submission review work with AJHG manuscripts
The most common timing mistake is assuming that because AJHG is a society flagship, technically solid genetics work should naturally get a full review.
That is not how it works.
The papers that move best here usually have:
- a broad human-genetics consequence visible in the title and abstract
- a clear explanation of why the finding matters beyond one local specialty
- stronger interpretation than raw association or cataloging alone
- a field-facing package rather than a niche-facing one
Those traits improve timing because they make the editorial choice simpler.
Submit if / Think twice if
Submit if the manuscript already behaves like broad human genetics, the relevance is obvious to readers across the field, and the argument extends beyond a narrow local use case.
Think twice if the strongest value is still niche clinical reporting, niche methods novelty, or model-organism biology with only indirect human consequence. In those cases, the time issue is usually a fit issue.
What should drive the submission decision instead
For AJHG, the better question is not only "how fast?" It is "does this look like flagship human genetics?"
That is why the better next reads are:
- American Journal of Human Genetics submission guide
- American Journal of Human Genetics impact factor
- How to avoid desk rejection at American Journal of Human Genetics
- How to choose the right journal for your paper
An AJHG fit check is usually more useful than fixating on the 4-week number alone.
Practical verdict
American Journal of Human Genetics review time is best understood as an officially disclosed within-4-weeks first-decision target sitting on top of a strong editorial fit screen. The journal is transparent enough to tell authors the front-end clock, but the real driver of speed is still whether the manuscript looks like broad human genetics from the first read.
Frequently asked questions
AJHG says the editors make every effort to reach decisions within 4 weeks of submission. That is the clearest official timing signal authors have for the first decision.
The official ASHG page says manuscripts that meet the general publication criteria are sent to at least two reviewers who have agreed in advance to assess the paper rapidly.
Yes. The same official language says all submissions are evaluated in depth by the editors first, so manuscripts that do not clear the journal's broad human-genetics bar can stop before or at the first reviewer-selection stage.
Field-level fit is the biggest variable. Papers that clearly matter to a broad human-genetics readership move more cleanly than papers that are mainly narrow clinical reporting, narrow methods work, or model-organism studies with only indirect human relevance.
Sources
Reference library
Use the core publishing datasets alongside this guide
This article answers one part of the publishing decision. The reference library covers the recurring questions that usually come next: whether the package is ready, what drives desk rejection, how journals compare, and what the submission requirements look like across journals.
Checklist system / operational asset
Elite Submission Checklist
A flagship pre-submission checklist that turns journal-fit, desk-reject, and package-quality lessons into one operational final-pass audit.
Flagship report / decision support
Desk Rejection Report
A canonical desk-rejection report that organizes the most common editorial failure modes, what they look like, and how to prevent them.
Dataset / reference hub
Journal Intelligence Dataset
A canonical journal dataset that combines selectivity posture, review timing, submission requirements, and Manusights fit signals in one citeable reference asset.
Dataset / reference guide
Peer Review Timelines by Journal
Reference-grade journal timeline data that authors, labs, and writing centers can cite when discussing realistic review timing.
Best next step
Use this page to interpret the status and choose the next sensible move.
For American Journal of Human Genetics, the better next step is guidance on timing, follow-up, and what to do while the manuscript is still in the system. Save the Free Readiness Scan for the next paper you have not submitted yet.
Guidance first. Use the scan for the next manuscript.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Same journal, next question
Supporting reads
Use this page to interpret the status and choose the next sensible move.
Guidance first. Use the scan for the next manuscript.